IP Library Granted Patent US 8,980,565
Granted Patent B2
US 8,980,565 · App. 14/013,745 · Granted Mar 17, 2015

Porphyrinic compounds for use in flow cytometry

Inventor: Jonathan S. Lindsey (Raleigh, NC)
Assignee: North Carolina State University
G01N21/6486G01N33/533
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,980,565
App. No.
14/013,745
Granted
Mar 17, 2015
Kind
B2
Abstract

The present invention provides a method of detecting (e.g., by flow cytometry) a target compound, cell or particle, wherein the target is labelled with a detectable luminescent compound. The method comprises utilizing as the detectable luminescent compound a compound comprising a porphyrinic macrocycle such as a porphyrin, chlorin, bacteriochlorin, or isobacteriochlorin. In particular embodiments, the detectable luminescent compound comprises a compound of the formula A-A′-Z—B′—B, wherein: A is a targeting group or member of a specific binding pair that specifically binds the detectable luminescent compound to the target compound, cell or particle; A′ is a linker group or covalent bond; B′ is a linker group or covalent bond; B is a water-soluble group; and Z is the porphyrinic macrocycle.

Claims (34)

1. In a method of detecting and distinguishing first and second target compounds, cells or particles, wherein said first target is labeled with a first detectable compound and said second target is labeled with a second detectable compound, the improvement comprising:

utilizing a compound comprising a first porphyrinic macrocycle as said first detectable compound and a compound comprising a second porphyrinic macrocycle as said second detectable compound;

wherein each of said first and second detectable compounds are excited at an excitation wavelength band;

wherein said first porphyrinic macrocycle comprises a porphyrin, chlorin, bacteriochlorin or isobacteriochlorin, and said second porphyrinic macrocycle comprises a porphyrin, chlorin, bacteriochlorin, or isobacteriochlorin;

and wherein:

(i) each of said first and second detectable compounds have a different emission wavelength band, said different emission wavelength bands characterized by peaks that are separated from one another by at least 5 nanometers; or

(ii) said second compound has a lifetime at least 20 percent greater than said first compound.

2. The method of claim 1 , wherein said first and second detectable luminescent compounds each comprise a compound of the formula A-A′-Z—B′—B, wherein:

A is a targeting group that specifically binds said detectable compound to said target compound, cell or particle;

A′ is a linking group or covalent bond;

B′ is a linking group or covalent bond;

B is a water-soluble group; and

Z is said porphyrinic macrocycle.

3. The method of claim 1 , wherein said detecting step is carried out by flow cytometry.

4. The method of claim 1 , wherein

both of said excitation wavelength bands have a peak between 350 and 900 nanometers; and

both of said emission wavelength bands have a peak between 550 and 1000 nanometers.

5. The method of claim 1 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by at least 50 nanometers.

6. The method of claim 1 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by 10 to 50 nanometers;

and wherein each of said different emission wavelength bands have a full width at half maximum peak of not more than 30 nanometers.

7. The method of claim 1 , wherein said first porphyrinic macrocycle is a chlorin or bacteriochlorin, and wherein said second porphyrinic macrocycle is a chlorin or bacteriochlorin.

8. The method of claim 7 , wherein said first and second detectable luminescent compounds each comprise a compound of the formula A-A′-Z—B′—B, wherein:

A is a targeting group that specifically binds said detectable compound to said target compound, cell or particle;

A′ is a linking group or covalent bond;

B′ is a linking group or covalent bond;

B is a water-soluble group; and

Z is said porphyrinic macrocycle.

9. The method of claim 7 , wherein said detecting step is carried out by flow cytometry.

10. The method of claim 7 , wherein

both of said excitation wavelength bands have a peak between 350 and 900 nanometers; and

both of said emission wavelength bands have a peak between 550 and 1000 nanometers.

11. The method of claim 7 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by at least 50 nanometers.

12. The method of claim 7 , wherein said different emission wavelength bands are characterized by peaks that are separated from one another by 10 to 50 nanometers;

and wherein each of said different emission wavelength bands have a full width at half maximum peak of not more than 30 nanometers.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042776/0077 →
Continuity (4)
Continuation 13459464 · Apr 30, 2012
Continuation 12095423
Provisional Application 60740896 · Nov 30, 2005
Related Publication 20140093887A1 · Apr 3, 2014